Literature DB >> 15214202

Clinicopathological concordance of dementia diagnoses by community versus tertiary care clinicians.

W Mok1, T W Chow, L Zheng, W J Mack, C Miller.   

Abstract

Subjects enrolled in the Autopsy Program at the University of Southern California Alzheimer's Disease Research Center may receive clinical diagnoses from primary care providers in the community or from specialists in neurology. We reviewed the autopsy concordance rates for 463 subjects for diagnoses made by both groups of clinicians. Seventy-seven percent of the sample met neuropathological criteria for Alzheimer's disease (AD). The overall diagnostic accuracy for this sample was 81 percent. Neurologists assessed 200 of the subjects (43 percent). The diagnostic accuracy for any clinical diagnosis among the non-neurologists was 84 percent, and 78 percent (p = 0.07) among neurologists. For AD, non-neurologists had a diagnostic concordance rate of 91 percent and neurologists 87 percent. Where neuropathological AD was missed, non-neurologists had failed to detect any cognitive impairment; neurologists had diagnosed Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS). Erroneous clinical diagnoses of AD missed dementia with Lewy bodies (DLB) or AD concurrent with Parkinson's disease (PD). Our findings identify specific foci for improving clinical diagnosis of dementia among all physicians managing dementia.

Entities:  

Mesh:

Year:  2004        PMID: 15214202      PMCID: PMC1626585          DOI: 10.1177/153331750401900309

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  14 in total

1.  Diagnosis of Alzheimer's disease in a community hospital-based brain bank program.

Authors:  G S Pearl
Journal:  South Med J       Date:  1997-07       Impact factor: 0.954

2.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors:  S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

3.  Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease.

Authors:  K L Newell; B T Hyman; J H Growdon; E T Hedley-Whyte
Journal:  J Neuropathol Exp Neurol       Date:  1999-11       Impact factor: 3.685

4.  Aging, memory, and mild cognitive impairment.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E Kokmen; E G Tangelos
Journal:  Int Psychogeriatr       Date:  1997       Impact factor: 3.878

5.  Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series.

Authors:  A Lim; D Tsuang; W Kukull; D Nochlin; J Leverenz; W McCormick; J Bowen; L Teri; J Thompson; E R Peskind; M Raskind; E B Larson
Journal:  J Am Geriatr Soc       Date:  1999-05       Impact factor: 5.562

6.  Neuropathologic diagnostic outcomes from a cohort of outpatients with suspected dementia.

Authors:  E B Larson; J K Edwards; E O'Meara; D Nochlin; S M Sumi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1996-11       Impact factor: 6.053

7.  Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers.

Authors:  H C Chui; J I Victoroff; D Margolin; W Jagust; R Shankle; R Katzman
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

8.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

9.  Accuracy of clinical operational diagnostic criteria for Alzheimer's disease in relation to different pathological diagnostic protocols.

Authors:  Z Nagy; M M Esiri; N J Hindley; C Joachim; J H Morris; E M King; B McDonald; S Litchfield; L Barnetson; K A Jobst; A D Smith
Journal:  Dement Geriatr Cogn Disord       Date:  1998 Jul-Aug       Impact factor: 2.959

10.  DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging.

Authors:  T J Ferman; G E Smith; B F Boeve; R J Ivnik; R C Petersen; D Knopman; N Graff-Radford; J Parisi; D W Dickson
Journal:  Neurology       Date:  2004-01-27       Impact factor: 9.910

View more
  20 in total

1.  The art of sharing the diagnosis and management of Alzheimer's disease with patients and caregivers: recommendations of an expert consensus panel.

Authors:  George T Grossberg; Daniel D Christensen; Patrick A Griffith; Diana R Kerwin; Gail Hunt; Eric J Hall
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

2.  In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18).

Authors:  Dean F Wong; Paul B Rosenberg; Yun Zhou; Anil Kumar; Vanessa Raymont; Hayden T Ravert; Robert F Dannals; Ayon Nandi; James R Brasić; Weiguo Ye; John Hilton; Constantine Lyketsos; Hank F Kung; Abhinay D Joshi; Daniel M Skovronsky; Michael J Pontecorvo
Journal:  J Nucl Med       Date:  2010-06       Impact factor: 10.057

3.  Prevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body Disorders.

Authors:  Thomas G Beach; Charles H Adler; Geidy Serrano; Lucia I Sue; D G Walker; Brittany N Dugger; Holly A Shill; Erika Driver-Dunckley; John N Caviness; Anthony Intorcia; Jessica Filon; Sarah Scott; Angelica Garcia; Brittany Hoffman; Christine M Belden; Kathryn J Davis; Marwan N Sabbagh
Journal:  J Parkinsons Dis       Date:  2016       Impact factor: 5.568

Review 4.  A clinicopathological approach to the diagnosis of dementia.

Authors:  Fanny M Elahi; Bruce L Miller
Journal:  Nat Rev Neurol       Date:  2017-07-14       Impact factor: 42.937

Review 5.  Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions.

Authors:  Brit Mollenhauer; Hans Förstl; Günther Deuschl; Alexander Storch; Wolfgang Oertel; Claudia Trenkwalder
Journal:  Dtsch Arztebl Int       Date:  2010-10-01       Impact factor: 5.594

6.  CETP polymorphisms associate with brain structure, atrophy rate, and Alzheimer's disease risk in an APOE-dependent manner.

Authors:  Elizabeth A Murphy; John Cooper Roddey; Linda K McEvoy; Dominic Holland; D J Hagler; Anders M Dale; James B Brewer
Journal:  Brain Imaging Behav       Date:  2012-03       Impact factor: 3.978

7.  The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design.

Authors:  L Bonanni; A Cagnin; F Agosta; C Babiloni; B Borroni; M Bozzali; A C Bruni; M Filippi; D Galimberti; R Monastero; C Muscio; L Parnetti; D Perani; L Serra; V Silani; P Tiraboschi; A Padovani
Journal:  Neurol Sci       Date:  2016-09-13       Impact factor: 3.307

Review 8.  Lewy body dementias.

Authors:  Zuzana Walker; Katherine L Possin; Bradley F Boeve; Dag Aarsland
Journal:  Lancet       Date:  2015-10-24       Impact factor: 79.321

9.  Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment.

Authors:  Linda K McEvoy; Christine Fennema-Notestine; J Cooper Roddey; Donald J Hagler; Dominic Holland; David S Karow; Christopher J Pung; James B Brewer; Anders M Dale
Journal:  Radiology       Date:  2009-02-06       Impact factor: 11.105

10.  Low sensitivity in clinical diagnoses of dementia with Lewy bodies.

Authors:  Peter T Nelson; Gregory A Jicha; Richard J Kryscio; Erin L Abner; Frederick A Schmitt; Gregory Cooper; Li O Xu; Charles D Smith; William R Markesbery
Journal:  J Neurol       Date:  2009-10-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.